This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Jim Cramer Explains Why Actavis Is the Healthcare Name to Own

Jim Cramer and Action Alerts PLUS Research Director Jack Mohr discuss why Actavis is severely undervalued and an extremely compelling healthcare investment at these levels.

Technology Won't Render Wall Street's Finest Obsolete Says Plumeri

Younger people may be technology savvy, but human beings will always like to speak to one another so financial advisers still play a valuable role.

Mattel Leads S&P 500 After Earnings Beat and Positive CEO Comments

Shares of Mattel Inc (MAT) rose following its earnings beat and positive comments by its CEO, making it TheStreet's Move of the Day.

Rough Day For Wall Street; Mylan, Teva Pop on Deal Reports

Equities were caught up in a global selloff on Friday, triggered by changes to Chinese market regulation.

Honeywell Cuts Full-Year Revenue Forecast, Analyst Is Optimistic

Shares of Honeywell (HON) are falling in Friday trading after the company reported a 5% fall in quarterly revenue and a lowered full-year revenue forecast.

China's Economy Is Surging 7% but Everyone Thinks That's Too Slow
  • Only in China would such a heady growth rate be considered a major cause for concern.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Submit an article to us!


DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs